Quarterly report pursuant to Section 13 or 15(d)

Share-Based Compensation (Tables)

v3.24.1.1.u2
Share-Based Compensation (Tables)
 6 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Expense

The Company recorded share-based compensation expense associated with the RSUs and RSAs in its accompanying unaudited interim consolidated statements of operations as follows:

 

    2024     2023     2024     2023  
    Three Months Ended March 31,     Six Months Ended March 31,  
    2024     2023     2024     2023  
Research and development   $ 28,268     $ 33,908     $ 52,821     $ 80,616  
General and administrative     32,127       23,090       57,579       67,999  
Share Based Compensation   $ 60,395     $ 56,998     $ 110,400     $ 148,615  
Schedule of Restricted Stock Units Activity

The following table summarizes RSU activity under the Plan:

 

          Weighted  
          Average Grant  
    RSU     Date Fair Value  
Unvested balance at October 1, 2023     2,326     $ 21.78  
Granted     73,440     $ 1.76  
Vested     (2,326 )   $ 21.78  
Unvested balance at March 31, 2024     73,440     $ 1.76  
Schedule of Restricted Stock Awards Activity

The following table summarizes RSA activity under the Plan:

 

          Weighted  
          Average Grant  
    RSA     Date Fair Value  
Unvested balance at October 1, 2023     5,514     $ 28.27  
Granted     63,819     $ 1.76  
Vested     (5,514 )   $ 28.27  
Unvested balance at March 31, 2024     63,819     $ 1.76